Patents Assigned to EXERKINE CORPORATION
  • Multi-nutrient composition
    Patent number: 11504413
    Abstract: A method of improving at least one of the following in an individual: lean mass, muscle strength, cognition, systemic inflammation levels, blood cholesterol levels, blood triglyceride levels and glucose tolerance is provided, comprising administering to the individual a multi-nutrient composition a protein, creatine, vitamin D, calcium and an n-3 fatty acid.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: November 22, 2022
    Assignee: Exerkine Corporation
    Inventors: Stuart Phillips, Gianni Parise, Jennifer Heisz
  • Weight management composition
    Patent number: 11167001
    Abstract: A method for promoting weight management in a mammal is provided, comprising administering to the mammal a weight loss agent and a mitochondria enhancing agent. Compositions for weight management are also provided.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: November 9, 2021
    Assignee: Exerkine Corporation
    Inventor: Mark Tarnopolsky
  • Therapeutic method of inducing mitochondrial biogenesis to treat skin and muscle pathologies
    Patent number: 10064919
    Abstract: A method of inducing mitochondrial biogenesis in a mammal is provided. The method comprises the step of administering to the mammal an interleukin-15 or nucleic acid encoding an interleukin-15 to the mammal.
    Type: Grant
    Filed: January 11, 2016
    Date of Patent: September 4, 2018
    Assignee: EXERKINE CORPORATION
    Inventors: Mark Tarnopolsky, Justin Crane